Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc
Failed Dissolution Specifications: below specification
- Agency
- FDA Drug
- Recall date
- Sep 17, 2026
- Status
- Ongoing
- Company
- Ajanta Pharma USA Inc
1. What product was recalled?
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Code or lot text: Lot: DJ25134, Exp 11/30/2028
- LOT
- Exp 11/30/2028
- LOT
- Lot: DJ25134
- NDC
- 27241-125
- NDC
- 27241-125-02
- NDC
- 27241-125-05
- NDC
- 27241-126
- NDC
- 27241-126-02
- NDC
- 27241-126-05
- RECALL-NUMBER
- D-0010-2027
- UPC
- 0327241125027
- UPC
- 0327241126024
2. Is my exact product affected?
Compare every printed identifier. A matching value can indicate that your product is included.
3. What is the hazard?
Failed Dissolution Specifications: below specification
4. What should I do now?
Follow the FDA recall notice and contact the recalling company for current instructions.
5. Where was it sold or distributed?
Nationwide
6. Were injuries or illnesses reported?
No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.
7. What remedy is available?
Follow the FDA recall notice and contact the recalling company for current instructions.
8. Is the recall active or closed?
The source status is Ongoing. The Recall Guy's urgency label is elevated, which is a separate deterministic site label.
9. When was the information checked?
Last checked .
- created
10. Where is the official source?
Open the official FDA Drug source
The Recall Guy normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.
